- Latest Deal Type
Out of Business
Adrenergics General Information
Developer of novel therapeutics designed to treat dilated cardiomyopathy (DCM). The company's therapeutics focus on developing medicines that are expected to modulate disease progression leading to improved outcomes, enabling patients to overcome difficult-to-treat situations.
Want to dig into this profile?
We’ll help you find what you need
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog »
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »